PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1972 September; 65(9): 813–818.
PMCID: PMC1644584

New horizons in psychopharmacology.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (946K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Akindele MO, Evans JI, Oswald I. Mono-amine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol. 1970 Jul;29(1):47–56. [PubMed]
  • Alexanderson B, Evans DA, Sjöqvist F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J. 1969 Dec 27;4(5686):764–768. [PMC free article] [PubMed]
  • ANGST J. A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacologia. 1961 Dec 19;2:381–407. [PubMed]
  • Arbab AG, Bonn JA, Hicks DC. Effect of propranolol on lactate induced phenomena in normal subjects. Br J Pharmacol. 1971 Feb;41(2):430P–430P. [PMC free article] [PubMed]
  • Bonn JA, Harrison J. Effect of propranolol in lactate-induced hypophosphataemia in man. Clin Sci. 1971 Feb;40(2):171–174. [PubMed]
  • Bonn JA, Harrison J, Rees WL. Lactate-induced anxiety: therapeutic application. Br J Psychiatry. 1971 Oct;119(551):468–470. [PubMed]
  • Carlsson A, Corrodi H, Fuxe K, Hökfelt T. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol. 1969 Mar;5(4):357–366. [PubMed]
  • Collins GG, Sandler M, Williams ED, Youdim MB. Multiple forms of human brain mitochondrial monoamine oxidase. Nature. 1970 Feb 28;225(5235):817–820. [PubMed]
  • Jones AB, Pare CM, Nicholson WJ, Price K, Stacey RS. Brain amine concentrations after monoamine oxidase inhibitor administration. Br Med J. 1972 Jan 1;1(5791):17–19. [PMC free article] [PubMed]
  • Jouvet M. Biogenic amines and the states of sleep. Science. 1969 Jan 3;163(3862):32–41. [PubMed]
  • Kelly D, Mitchell-Heggs N, Sherman D. Anxiety and the effects of sodium lactate assessed clinically and physiologically. Br J Psychiatry. 1971 Aug;119(549):129–141. [PubMed]
  • KLINE NS. Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions. Ann N Y Acad Sci. 1954 Apr 30;59(1):107–132. [PubMed]
  • MACLEAN R, NICHOLSON WJ, PARE CM, STACEY RS. EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN. Lancet. 1965 Jul 31;1(7405):205–208. [PubMed]
  • Abenson MH. Chlorimipramine in the treatment of severe depression. Br J Psychiatry. 1971 Aug;119(549):230–231. [PubMed]
  • PARE CM, REES L, SAINSBURY MJ. Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet. 1962 Dec 29;2(7270):1340–1343. [PubMed]
  • REES L, DAVIES B. A controlled trial of phenelzine ("Nardil") in the treatment of severe depressive illness. J Ment Sci. 1961 May;107:560–566. [PubMed]
  • Schildkraut JJ, Watson R, Draskoczy PR. Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet. 1971 Aug 28;2(7722):485–486. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press